Chemours Total Assets Growth & History (CC)
Chemours's total assets was $7.38B for fiscal 2025.
View full Chemours company overviewChemours annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $7.38B | −$127.0M | −1.69% |
| 2024 | 2024-12-31 | $7.51B | −$732.0M | −8.88% |
| 2023 | 2023-12-31 | $8.24B | $601.0M | +7.87% |
| 2022 | 2022-12-31 | $7.64B | $90.0M | +1.19% |
| 2021 | 2021-12-31 | $7.55B | $468.0M | +6.61% |
| 2020 | 2020-12-31 | $7.08B | −$176.0M | −2.42% |
| 2019 | 2019-12-31 | $7.26B | −$104.0M | −1.41% |
| 2018 | 2018-12-31 | $7.36B | $69.0M | +0.95% |
| 2017 | 2017-12-31 | $7.29B | $1.23B | +20.35% |
| 2016 | 2016-12-31 | $6.06B | −$238.0M | −3.78% |
| 2015 | 2015-12-31 | $6.30B | $339.0M | +5.69% |
| 2014 | 2014-12-31 | $5.96B | — | — |
Chemours quarterly total assets
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $7.15B | −$312.0M | −4.18% |
| Q1 2026 | 2026-03-31 | $7.27B | −$109.0M | −1.48% |
| Q4 2025 | 2025-12-31 | $7.38B | −$127.0M | −1.69% |
| Q3 2025 | 2025-09-30 | $7.55B | $89.0M | +1.19% |
| Q2 2025 | 2025-06-30 | $7.46B | $216.0M | +2.98% |
| Q1 2025 | 2025-03-31 | $7.38B | −$607.0M | −7.60% |
| Q4 2024 | 2024-12-31 | $7.51B | −$732.0M | −8.88% |
| Q3 2024 | 2024-09-30 | $7.46B | −$491.0M | −6.18% |
| Q2 2024 | 2024-06-30 | $7.25B | −$414.0M | −5.40% |
| Q1 2024 | 2024-03-31 | $7.98B | $359.0M | +4.71% |
| Q4 2023 | 2023-12-31 | $8.24B | $601.0M | +7.87% |
| Q3 2023 | 2023-09-30 | $7.95B | $203.0M | +2.62% |
| Q2 2023 | 2023-06-30 | $7.66B | −$70.0M | −0.91% |
| Q1 2023 | 2023-03-31 | $7.62B | $100.0M | +1.33% |
| Q4 2022 | 2022-12-31 | $7.64B | $90.0M | +1.19% |
| Q3 2022 | 2022-09-30 | $7.75B | $215.0M | +2.86% |
| Q2 2022 | 2022-06-30 | $7.73B | $251.0M | +3.36% |
| Q1 2022 | 2022-03-31 | $7.52B | $354.0M | +4.94% |
| Q4 2021 | 2021-12-31 | $7.55B | $468.0M | +6.61% |
| Q3 2021 | 2021-09-30 | $7.53B | $582.0M | +8.38% |
| Q2 2021 | 2021-06-30 | $7.48B | $445.0M | +6.33% |
| Q1 2021 | 2021-03-31 | $7.17B | $222.0M | +3.20% |
| Q4 2020 | 2020-12-31 | $7.08B | −$176.0M | −2.42% |
| Q3 2020 | 2020-09-30 | $6.95B | −$508.0M | −6.81% |
| Q2 2020 | 2020-06-30 | $7.03B | −$399.0M | −5.37% |
| Q1 2020 | 2020-03-31 | $6.95B | −$377.0M | −5.15% |
| Q4 2019 | 2019-12-31 | $7.26B | −$104.0M | −1.41% |
| Q3 2019 | 2019-09-30 | $7.46B | −$56.0M | −0.75% |
| Q2 2019 | 2019-06-30 | $7.43B | $95.0M | +1.29% |
| Q1 2019 | 2019-03-31 | $7.33B | −$159.0M | −2.12% |
| Q4 2018 | 2018-12-31 | $7.36B | $69.0M | +0.95% |
| Q3 2018 | 2018-09-30 | $7.51B | $392.0M | +5.51% |
| Q2 2018 | 2018-06-30 | $7.34B | $286.0M | +4.06% |
| Q1 2018 | 2018-03-31 | $7.48B | $1.20B | +19.13% |
| Q4 2017 | 2017-12-31 | $7.29B | $1.23B | +20.35% |
| Q3 2017 | 2017-09-30 | $7.12B | $831.0M | +13.21% |
| Q2 2017 | 2017-06-30 | $7.05B | $831.0M | +13.36% |
| Q1 2017 | 2017-03-31 | $6.28B | −$98.0M | −1.54% |
| Q4 2016 | 2016-12-31 | $6.06B | −$238.0M | −3.78% |
| Q3 2016 | 2016-09-30 | $6.29B | −$162.0M | −2.51% |
| Q2 2016 | 2016-06-30 | $6.22B | −$464.0M | −6.94% |
| Q1 2016 | 2016-03-31 | $6.38B | — | — |
| Q4 2015 | 2015-12-31 | $6.30B | $339.0M | +5.69% |
| Q3 2015 | 2015-09-30 | $6.45B | — | — |
| Q2 2015 | 2015-06-30 | $6.68B | — | — |
| Q4 2014 | 2014-12-31 | $5.96B | — | — |
Chemours total assets trends
Over the last five fiscal years, Chemours's total assets increased from $7.08B to $7.38B, a change of $300.0M. The latest reported quarter, Q2 2026, shows $7.15B.
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Chemours source filings ↗Community posts
Chemours, DuPont and Corteva agree to a $455 million PFAS settlement
Chemours ($CC), DuPont ($DD) and Corteva ($CTVA) reached an agreement to resolve PFAS-related claims brought by North Carolina and 11 local government entities. The settlement provides for $455 million in nominal payments over 15 years. Che ...